Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | LDHB | P07195 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Peroxide SCHEMBL28780383 | 0.96 | — | — | |
| SCHEMBL9425846 | 0.96 | CRBN (0.50) | CRBNLMNATSHRNFKB1CYP1A2 | |
| SCHEMBL22493 | 0.96 | — | — | |
| SCHEMBL23002882 | 0.93 | — | — | |
| SCHEMBL17353590 | 0.93 | — | — | |
| Urea SCHEMBL27520574 | 0.93 | CRBN (0.47) | CRBNLMNATSHRNFKB1CYP1A2 | |
| Hydrochloric Acid SCHEMBL2672461 | 0.93 | — | — | |
| Ammonia Solution, Strong SCHEMBL27866084 | 0.93 | — | — | |
| Water SCHEMBL6337702 | 0.93 | — | — | |
| SCHEMBL28220720 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080262261-A1 | STABLE LIQUID BIURET MODIFIED AND BIURET ALLOPHANATE MODIFIED TOLUENE DIISOCYANATES, PREPOLYMERS THEREOF, AND PROCESSES FOR THEIR PREPARATION | BAYER MATERIALSCIENCE LLC (US) | 2008-10-23 | — | — | US | claimed |
| US-7378543-B2 | Stable liquid biuret modified and biuret allophanate modified toluene diisocyanates, prepolymers thereof, and processes for their preparation | BAYER MATERIALSCIENCE LLC (US) | 2008-05-27 | — | — | US | claimed |
| US-20080033203-A1 | Stable liquid biuret modified and biuret allophanate modified toluene diisocyanates, prepolymers thereof, and processes for their preparation | SLACK WILLIAM E | 2008-02-07 | — | — | US | claimed |
| EP-1651594-A2 | STABLE LIQUID BIURET MODIFIED AND BIURET ALLOPHANATE MODIFIED TOLUENE DIISOCYANATES, PREPOLYMERS THEREOF, AND PROCESSES FOR THEIR PREPARATION | Bayer MaterialScience LLC (US) | 2006-05-03 | — | — | EP | claimed |
| WO-2005009945-A2 | STABLE LIQUID BIURET MODIFIED AND BIURET ALLOPHANATE MODIFIED TOLUENE DIISOCYANATES, PREPOLYMERS THEREOF, AND PROCESSES FOR THEIR PREPARATION | BAYER MATERIALSCIENCE LLC (US) | 2005-02-03 | — | — | WO | claimed |
| US-20050020795-A1 | STABLE LIQUID BIURET MODIFIED AND BIURET ALLOPHANATE MODIFIED DIPHENYLMETHANE DIISOCYANATES, PREPOLYMERS THEREOF, AND PROCESSES FOR THEIR PREPARATION | COVESTRO LLC | 2005-01-27 | — | — | US | claimed |
| US-20050020765-A1 | Stable liquid biuret modified and biuret allophanate modified toluene diisocyanates, prepolymers thereof, and processes for their preparation | BAYER MATERIALSCIENCE LLC | 2005-01-27 | — | — | US | claimed |
| US-6838542-B1 | Stable liquid biuret modified and biuret allophanate modified diphenylmethane diisocyanates, prepolymers thereof, and processes for their preparation | BAYER MATERIALSCIENCE LLC (US) | 2005-01-04 | — | — | US | claimed |
| JP-4309516-A | — | — | None | — | — | JP | disclosed |
| CN-113755112-B | Adhesive sheet, adherend with adhesive sheet, and method for using adhesive sheet | 爱天思株式会社 | 2024-10-18 | — | — | CN | disclosed |
| CN-118421251-A | Adhesive and adhesive sheet | 爱天思株式会社 | 2024-08-02 | — | — | CN | disclosed |
| CN-114206459-B | Adhesive and adhesive sheet | 爱天思株式会社 | 2024-07-12 | — | — | CN | disclosed |
| CN-118290706-A | Preparation method of polyisocyanate composition | 万华化学（宁波）有限公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-3356441-B1 | BIURET POLYISOCYANATE COMPOSITION | VENCOREX FRANCE (FR) | 2024-05-22 | — | — | EP | disclosed |
| EP-0929325-A1 | ePTFE SMALL CALIBER VASCULAR GRAFTS WITH SIGNIFICANT PATENCY ENHANCEMENT VIA A SURFACE COATING WHICH CONTAINS COVALENTLY BONDED HEPARIN | Meadox Medicals, Inc. (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998010806-A1 | ePTFE SMALL CALIBER VASCULAR GRAFTS WITH SIGNIFICANT PATENCY ENHANCEMENT VIA A SURFACE COATING WHICH CONTAINS COVALENTLY BONDED HEPARIN | MEADOX MEDICALS, INC. (US) | 1998-03-19 | — | — | WO | disclosed |
| CN-1130196-A | Method for preparing low fogging polyurethane foam and special poly suboxygen alkyl-polyol for the same | BASF AG (DE) | 1996-09-04 | — | — | CN | disclosed |
| US-5473032-A | Includes acrylic copolymer having hydroxyl groups | HERBERTS GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1995-12-05 | — | — | US | disclosed |
| JP-H04309516-A | PRODUCTION OF THERMOPLASTIC POLYURETHANE RESIN | SANYO CHEM IND LTD | 1992-11-02 | — | — | JP | disclosed |
| US-4611083-A | FLEXIBLE POLYURETHANE FOAMS | BASF AKTIENGESELLSCHAFT (DE) | 1986-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033203-A1 | Stable liquid biuret modified and biuret allophanate modified toluene diisocyanates, prepolymers thereof, and processes for their preparation | KYAT1, KYNU, TDO2 | CRBN 1622/4885LMNA 427/4885TSHR 3724/4885 |
| US-20080262261-A1 | STABLE LIQUID BIURET MODIFIED AND BIURET ALLOPHANATE MODIFIED TOLUENE DIISOCYANATES, PREPOLYMERS THEREOF, AND PROCESSES FOR THEIR PREPARATION | KYAT1, KYNU, TDO2 | CRBN 1622/4885LMNA 427/4885TSHR 3724/4885 |
| US-20050020765-A1 | Stable liquid biuret modified and biuret allophanate modified toluene diisocyanates, prepolymers thereof, and processes for their preparation | KYAT1, KYNU, TDO2 | CRBN 1622/4885LMNA 427/4885TSHR 3724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.